Perianal Paget's disease as spread from non-invasive colorectal adenomas.


Journal

Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 22 05 2020
revised: 22 06 2020
accepted: 20 07 2020
pubmed: 25 7 2020
medline: 28 9 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Paget's disease of the perianal skin is a rare form of extramammary Paget's disease, and may be a primary intraepithelial adnexal neoplasm or secondary due to spread from an underlying colorectal lesion, nearly always colorectal adenocarcinoma. Secondary perianal Paget's disease associated with non-invasive colorectal adenomas is exceedingly uncommon, with only a few reported cases. Herein, we present the clinical and pathological features of the largest series of secondary perianal Paget's disease arising in association with colorectal adenomas. There was gender parity and the median age was 72 years (range = 68-76 years). In all cases, perianal Paget's disease was associated with colorectal adenomas, including three (75%) conventional tubular adenomas and one (25%) tubulovillous adenoma with serrated foci. All adenomas had high-grade dysplasia and one had intramucosal adenocarcinoma (lamina propria invasion; Tis), but all lacked submucosal invasion. The intraepithelial Paget's cells showed a colorectal phenotype by immunohistochemistry in all cases. At follow-up, two patients had no evidence of disease at 6 and 87 months, one had residual perianal Paget's disease at 8 months and one developed invasive adenocarcinoma of the perianal tissue at 36 months. Similar to its mammary analogue, secondary perianal Paget's disease may arise in association with invasive and/or in-situ colorectal lesions. Although the latter is an uncommon presentation of a recognised rare disease, knowledge of this phenomenon is important to forestall overdiagnosis of invasion and potential overtreatment. The clinical course is variable, such that close follow-up is required.

Identifiants

pubmed: 32705713
doi: 10.1111/his.14218
pmc: PMC9257882
mid: NIHMS1820780
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-280

Subventions

Organisme : NCI NIH HHS
ID : T32 CA193145
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Am J Surg Pathol. 1998 Feb;22(2):170-9
pubmed: 9500217
Gastroenterology Res. 2016 Dec;9(6):99-102
pubmed: 28058078
Hematol Oncol Clin North Am. 2019 Feb;33(1):73-85
pubmed: 30497678
Cancer Med. 2018 Jun;7(6):2307-2318
pubmed: 29722170
Breast Cancer Res Treat. 2013 Aug;141(1):1-12
pubmed: 23929251
BJOG. 2005 Mar;112(3):273-9
pubmed: 15713139
Cancer. 1963 Mar;16:387-403
pubmed: 13953662
Int J Surg Pathol. 2009 Feb;17(1):42-5
pubmed: 18499687
Br J Surg. 1989 Jan;76(1):60-3
pubmed: 2537129
Int J Colorectal Dis. 1992 Sep;7(3):167-9
pubmed: 1328429
Int J Colorectal Dis. 2008 Nov;23(11):1125-30
pubmed: 18535830
J Clin Pathol. 1973 Jan;26(1):25-31
pubmed: 4540378
Arch Pathol Lab Med. 1998 Dec;122(12):1077-81
pubmed: 9870855
Diagn Pathol. 2020 Mar 24;15(1):29
pubmed: 32209119
Int J Colorectal Dis. 2016 Jan;31(1):29-34
pubmed: 26260479
Histopathology. 2017 Feb;70(3):466-472
pubmed: 27676454
Histopathology. 2002 Aug;41(2):177-9
pubmed: 12147102
Br J Dermatol. 2005 Sep;153(3):677-9
pubmed: 16120171

Auteurs

Danielle Hutchings (D)

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Annika Windon (A)

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Naziheh Assarzadegan (N)

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Kevan J Salimian (KJ)

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Lysandra Voltaggio (L)

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Elizabeth A Montgomery (EA)

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH